Vignoli M, Stecca B, Furlini G, Re M C, Mantovani V, Zauli G, Visani G, Colangeli V, La Placa M
Department of Clinical and Experimental Medicine, University of Bologna, Italy.
AIDS. 1998 Jun 18;12(9):999-1005.
Haematopoietic progenitor cells (HPC) of HIV-1-infected patients are severely compromised in their replication and clonogenic capacities, and show an enhanced propensity to apoptosis, despite the lack of productive or latent HIV-1 infection.
To investigate telomerase enzyme levels in CD34+ HPC isolated from HIV-1-infected patients, because the absence of telomerase activity has been found to be correlated with a diminished replication potential.
Telomerase levels were measured by a PCR-based telomeric repeat amplification protocol. CD34+ HPC isolated from the peripheral blood of 11 HIV-1-infected patients were compared with CD34+ HPC isolated from peripheral blood (nine subjects) or bone marrow (six subjects) from 15 healthy donors. Telomerase levels were also studied in normal HPC after exposure to either gp120 or transforming growth factor (TGF)-beta1.
CD34+ HPC isolated from either peripheral blood or bone marrow from healthy donors expressed a high level of telomerase activity. On the contrary, CD34+ HPC isolated from HIV-1-seropositive patients did not express any detectable telomerase activity in nine patients, and a clearly reduced enzymatic activity in two patients. Furthermore, telomerase activity in normal CD34+ HPC exposed to recombinant gp120 was significantly reduced, and to a higher extent than in CD34+ HPC exposed to recombinant TGF-beta1.
This is the first study to demonstrate severely impaired telomerase activity in uninfected CD34+ HPC isolated from HIV-1-infected patients. The mechanism underlying this impairment probably involves the interaction of HIV-1 envelope glycoprotein gp120 with the cell membrane. These results may add to our understanding of the pathogenesis of the lesion of the HPC compartment.
尽管缺乏活跃或潜伏的HIV-1感染,但HIV-1感染患者的造血祖细胞(HPC)在复制和克隆形成能力方面严重受损,且凋亡倾向增强。
研究从HIV-1感染患者中分离出的CD34+HPC中的端粒酶水平,因为已发现端粒酶活性缺失与复制潜能降低相关。
通过基于PCR的端粒重复序列扩增法测量端粒酶水平。将从11例HIV-1感染患者外周血中分离出的CD34+HPC与从15名健康供者的外周血(9名受试者)或骨髓(6名受试者)中分离出的CD34+HPC进行比较。还研究了正常HPC在暴露于gp120或转化生长因子(TGF)-β1后的端粒酶水平。
从健康供者的外周血或骨髓中分离出的CD34+HPC表达高水平的端粒酶活性。相反,从HIV-1血清阳性患者中分离出的CD34+HPC,9例患者未检测到任何端粒酶活性,2例患者的酶活性明显降低。此外,暴露于重组gp120的正常CD34+HPC中的端粒酶活性显著降低,且降低程度高于暴露于重组TGF-β1的CD34+HPC。
这是第一项证明从HIV-1感染患者中分离出的未感染CD34+HPC中端粒酶活性严重受损的研究。这种损伤的潜在机制可能涉及HIV-1包膜糖蛋白gp120与细胞膜的相互作用。这些结果可能有助于我们理解HPC区室病变的发病机制。